Perturbing the Normal Level of SIDT1 Suppresses the Naked ASO Effect
Although antisense oligonucleotide (ASO) therapeutics can be taken up by living cells without carrier molecules, a large part of incorporated ASOs are trapped in the endosomes and do not exert therapeutic effects. To improve their therapeutic effects, it would be important to elucidate the mechanism...
Enregistré dans:
Auteurs principaux: | Masayuki Takahashi, Mineaki Seki, Masayuki Nashimoto, Tomohiro Kabuta |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Hindawi Limited
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6bbd43e111d942ffb5f9e3594e13f4dc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
DNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications
par: I. B. K. Thomas, et autres
Publié: (2021) -
Trans-tail regulation-mediated suppression of cryptic transcription
par: Jungmin Choi, et autres
Publié: (2021) -
Epigenetic modulation of selected immune response genes and altered functions of T lymphocytes and macrophages collectively contribute to autoimmune diabetes protection
par: Arathi Jayaraman, et autres
Publié: (2021) -
Editor'den [Editorial] 30. Yilimizi Kutluyoruz [We are celebrating the 30th Anniversary]
par: N. Leyla Acan, et autres
Publié: (2006) -
The insulin centennial—100 years of milestones in biochemistry
par: Alan D. Attie, et autres
Publié: (2021)